Navigating the Evolving Pharma M&A Landscape: Trends, Challenges, and Opportunities

October 23nd  | 10am EST - 11am EST

A panel discussion with:

• Oliver Barnes, US Pharmaceutical & Biotech Correspondent, Financial Times
• Christian Schenk, Investment Director, Apposite Capital
• Konstantina Katcheves, SVP, Global Business Development and Acquisitions, Teva Pharmaceuticals
• Corey Brown, Partner, M&A Practice Group Co-Chair, Foley Hoag
• Michelle Li, Vice President and Head, BD&L Transactions, Bristol Myers Squibb 
  
  

The pharmaceutical industry is witnessing unprecedented levels of merger and acquisition (M&A) activity, driven by factors such as technological advancements, market dynamics, and shifting regulatory landscapes. In this dynamic environment, staying abreast of the latest trends and navigating the complexities of M&A transactions is paramount for industry stakeholders. This webinar seeks to provide insights into the current state of the pharma M&A landscape, exploring emerging trends, key challenges, and potential opportunities for stakeholders across the value chain.

• Trends Shaping the Pharma M&A Landscape
• Navigating Regulatory and Compliance Challenges
• Assessing Valuation and Due Diligence Strategies
• Unlocking Value and Integration Success